Here are relevant reports on : chemical-reagents-market
-
North American Top Chemical Distributors – Company Profiles
This service profiles top players within the chemical distribution industry in North America, detailing the market segments they cover, the chemical they distribute, their global locations, financial sale, revenues, ratios, M&A's, product launches and their future plans.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
UK Top Chemical Distributors – Company Profiles
This service profiles top players within the chemical distribution industry in Europe, detailing the market segments they cover, the chemical they distribute, their global locations, financial sale, revenues, ratios ,M&A's, product launches and their future plans. The research service may highlight areas for possible partnerships between these key participants and smaller, emerging companies or service providers such as companies dealing with packaging or raw materials distribution. Some of them are brenntag, helm, azelis, imcd, omya, caldic, DKSH ,etc.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, CLIA, Western Blot), Specimen (Blood, Saliva, Urine), Application (Infectious Diseases, Endocrinology), End User (Hospitals & Clinics, Laboratories) - Global Forecast to 2030
The global immunoassay market, valued at US$34.4 billion in 2024, stood at US$35.5 billion in 2025 and is projected to advance at a resilient CAGR of 6.1% from 2025 to 2030, culminating in a forecasted valuation of US$47.7 billion by the end of the period. This growth is primarily driven by the increasing prevalence of chronic and infectious diseases worldwide, which has boosted the demand for early and accurate diagnostic solutions.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Next-generation Sequencing Market by Product (Reagents, Kits, Platforms), Service (CHIP Sequencing, Whole Genome, Methyl, RNA Sequencing), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Application, Competition - Global Forecast to 2031
The global next-generation sequencing market is projected to reach USD 27.14 billion by 2031, growing at a CAGR of 14.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Electrophoresis Market by Product (Reagents (Protein & Nucleic Acid), (Gel Electrophoresis (1D & 2D), Capillary Electrophoresis (CZE, CGE), GDS, Software), Application (Research, Diagnostics), End User (Hospitals) & Region - Global Forecast to 2028
The global electrophoresis market, valued at US$2.9 billion in 2022, stood at US$3.1 billion in 2023 and is projected to advance at a resilient CAGR of 5.7% from 2023 to 2028, culminating in a forecasted valuation of US$4.1 billion by the end of the period. The growth in this market is attributed to the the growing industry-academia research collaboations, and increasing number of clinical, forensic and research labs screening will drive the growth of the market.
- Published: April 2023
- Price: $ 4950
- TOC Available:
-
Proteomics Market by Instrumentation (Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray), Reagents, Services (Core, Bioinformatics), Software, Workflow (Sample Prep, Separation), Applications, End User, Competition - Global Forecast to 2031
The proteomics market is expected to reach USD 67.55 billion in 2031 from USD 39.84 billion in 2026, at a CAGR of 11.1% during the forecast period. The key players include Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Shimadzu Corporation (Japan), Waters Corporation (US), Bio-Rad Laboratories, Inc. (US), Bruker (US), Revvity (US), and Illumina, Inc. (US), among others.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Preimplantation Genetic Testing Market by Product & Service (Reagents, Consumables, Instruments, Software), Technology (NGS, PCR, SNP, CGH), Procedure (Screening, Diagnosis), Application (Aneuploidy, HLA Typing), Type of cycle - Global Forecast to 2030
The global preimplantation genetic testing market, valued at US$636.4 million in 2024, stood at US$690.2 million in 2025 and is projected to advance at a resilient CAGR of 10.5% from 2024 to 2030, culminating in a forecasted valuation of US$1,135.0 million by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Genomics Market by Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) - Global Forecast to 2030
The global genomics market, valued at US$44.52 billion in 2024, stood at US$47.07 billion in 2025 and is projected to advance at a resilient CAGR of 12.6% from 2024 to 2030, culminating in a forecasted valuation of US$85.09 billion by the end of the period. The growth of the genomics market is driven by increasing government funding for genomics projects, a rising prevalence of viral and inherited disorders, advancements in NGS platforms, and the expansion of applications in genomics.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Preclinical Imaging Market by Product (Optical Imaging (Bioluminescence), Nuclear Imaging (PET, SPECT), MRI, Reagents (Luciferins, Infrared Dyes), Software), Application (Onco, Cardio), End User (Pharma, Biotech, Academic, CRO) - Global Forecast to 2030
The global preclinical imaging market, valued at US$3.36 billion in 2024, stood at US$3.53 billion in 2025 and is projected to advance at a resilient CAGR of 4.5% from 2025 to 2030, culminating in a forecasted valuation of US$4.39 billion by the end of the period.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Epigenetics Market by Product & Service (Enzymes, Kits & Reagents (Antibodies), Software), Method (DNA Methylation, Histone Modification), Technique (NGS, PCR), Application (Oncology, Immunology, Developmental Biology), End User - Global Forecast to 2030
The global epigenetics market, valued at USD 2.03 billion in 2024, stood at USD 2.24 billion in 2025 and is projected to advance at a resilient CAGR of 13.9% from 2025 to 2030, culminating in a forecasted valuation of USD 4.29 billion by the end of the period. The major factors driving the growth in epigenetics market includes reduced sequencing costs and accelerated turnaround times to improve access and affordability of epigenetic analysis.
- Published: July 2025
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
